Abstract
Coenzyme Q10 (CoQ10) is an essential compound that is involved in energy production and is a lipid-soluble antioxidant. Although it has been proposed as an antiaging and a health-supporting supplement, its low bioavailability remains a significant issue. Concurrent food intake enhances the absorption of orally administered CoQ10, but it has not been fully established whether specific food substances affect intestinal CoQ10 absorption. Therefore, to determine whether the bioavailability of supplemental CoQ10 is affected by diet, P30, a granulated and reduced form of CoQ10, was dispersed in four different foods, clear soup, miso soup, milk soup, and raw egg sauce. Those foods which contained CoQ10 were consumed on different occasions at intervals of 6–14 weeks by the same participants. Thirteen participants were recruited in the single-dose and repeated clinical study. When miso soup containing P30 was provided, the serum CoQ10 concentration increased faster than when participants consumed other P30-containing soups or a P30-containing raw egg sauce. The area under the curve for serum CoQ10 during the first 5 h after consumption of the P30-containing miso soup was approximately 1.5 times larger than those after the consumption of other P30-containing meals. These data imply that the absorption of CoQ10 supplements can be enhanced by consuming them with food and in particular with specific food substances, such as miso soup.
1. Introduction
Coenzyme Q10 (CoQ10), a vitamin-like substance, is involved in energy production and is a lipid-soluble antioxidant [1–3]. Many studies have reported a relationship between CoQ10 and aging. For example, the amount of CoQ10 in muscles and organs decreases with age [4], as does the serum CoQ10 concentration and that of the reduced form [5] in healthy adults. Both blood levels and the ratio of the reduced form of CoQ10 concentration to total coenzyme Q10 in hospitalized elderly people were lower than that in the healthy elderly people [6]. Also, many studies have shown associations between serum CoQ10 status and health [7–11]. In addition, CoQ10 supplementation has been shown to ameliorate the symptoms of some geriatric disorders and to improve the quality of life of humans and some laboratory animals. CoQ10 supplementation ameliorates high blood pressure [12], glucose metabolism in diabetes [13], and the symptoms of Parkinson's disease [14] and reduces peripheral oxidative stress and inflammation in interferon β-1a-treated multiple sclerosis [15]. It can also increase the vitality of patients undergoing medical treatment and of the elderly residents of nursing homes [16–18]. Furthermore, it alleviates fatigue in patients with chronic fatigue syndrome [19, 20], hyperlipidemia [21], and in those with end-stage heart failure awaiting cardiac transplantation [22]. In older rats, CoQ10 supplementation has been shown to alleviate diabetes-induced learning and memory deficits and to improve cognitive performance when administered at a high dose [23]. In the senescence-accelerated prone 8 mouse, CoQ10 supplementation counteracts the deleterious effects of physical exercise-derived reactive oxygen species, improving mitochondrial function [24]. Thus, CoQ10 may be useful as an antiaging and health-supporting supplement.
In general, the absorption of compounds from the gastrointestinal tract is one of the most important determinants of oral bioavailability. Intestinal absorption of supplemental CoQ10 is slow and limited because of the compound's hydrophobicity and high molecular weight. Many types of CoQ10 delivery system have been developed that aim to increase the bioavailability of supplemental CoQ10, such as self-emulsifying drug delivery systems, nanotechnology-based drug delivery systems, cyclodextrin complexes, CoQ10-solanesyl poly(ethylene glycol) succinate micelles, and a reduced form of CoQ10 that is both emulsified and solubilized [25–27]. In addition, the concurrent consumption of food enhances the rate of the absorption of orally administered supplemental CoQ10 [28]. Therefore, the consumption of CoQ10-fortified foods may be a useful way of increasing the bioavailability of CoQ10.
It is well known that the absorption of nutrients, such as vitamins and minerals, is affected by the food items concurrently consumed or their components. For example, the enhancement of β-carotene absorption by mayonnaise consumption [29], of carotenoid absorption by avocado or avocado oil consumption [30], of vitamin E absorption by egg consumption [31], and of nonheme iron absorption by meat protein and vitamin C consumption, have been reported [32–34]. Conversely, some dietary fibers suppress the absorption of β-carotene, lycopene, and lutein [35]. Additionally, tannins, phytic acid, polyphenols, and calcium inhibit the absorption of nonheme iron [36–39]. Thus, the absorption of supplemental CoQ10 may also be affected by the food or a component with which it is consumed, although no previous studies have addressed this issue. Therefore, knowledge of the food items that could enhance the absorption of orally administered CoQ10 is crucial for the development of appropriate functional CoQ10-fortified foods.
Previously, we investigated the association between dietary habits and serum CoQ10 levels before and after long-term supplementation with a reduced form of CoQ10 [40, 41]. People with higher basal serum CoQ10 concentrations tended to consume more soy products [40], and those who had a higher increase in serum CoQ10 concentrations after the 1-year supplementation tended to consume more dairy products and eggs [41]. These results remind us that soy products, dairy products, and eggs might positively affect the absorption of CoQ10 supplements.
In this study, we investigated the effect of various foods on the bioavailability of supplemental CoQ10 using P30, a granulated and reduced form of CoQ10 supplement, and a typical Japanese meal, consisting of steamed rice, grilled salmon with marinated Japanese radish, boiled spinach, and soup. P30 was suspended in the soup or raw egg sauce in advance, before being provided to the participants. Miso soup, milk soup, and raw egg sauce were used as foods containing soy products, daily products, and eggs, respectively. Clear soup, which is seasoned with salt, was used as a reference food. The soup consumed was different in each experiment. Serum CoQ10 concentration was determined before, and 1.5, 3, and 5 h after eating the meals, and the bioavailability of CoQ10 was compared among the various foods that were concurrently consumed.
2. Materials and Methods
2.1. CoQ10 Supplements
A granulated, solubilized, and reduced form of CoQ10 supplement, P30, was used in the study. P30 contains 30 w/w% of reduced CoQ10 (120 mg per sachet), dextrin, gum Arabic, and L-ascorbate. These supplements were provided by the Kaneka Corporation (Osaka, Japan).
2.2. Study Design
Thirteen healthy volunteers (1 man and 12 women), who were students or staff at Wayo Women's University, participated in the study. Each participant took a CoQ10 supplement with a meal on four occasions, with the food type containing the CoQ10 differing on each occasion. Table 1 shows the meal composition, the sauce of the CoQ10, the nutrient content of the meals. Using the data by Kubo et al. [42], CoQ10 content obtained from the meals in the clear soup, miso soup, milk soup, and raw egg source experiments were estimated as 0.52, 0.55, 0.56, and 0.59 mg, respectively, and these were the less than one two-hundredth of the CoQ10 supplements ingested. It suggests that the effect of CoQ10 content in meals itself was vanishingly low. The number of participants in each experiment is shown in . Photos of the meal components provided for the subjects are shown in . In the experiments, each participant ingested 120 mg of reduced CoQ10 (a sachet of P30) suspended in the food (indicated by red arrowheads in ). In the meals containing P30, the ratio of the concentrations of the reduced form of CoQ10 concentration to total coenzyme Q10 was >99%. To minimize the number of confounding factors, the same meal was consumed in each experiment, with the exception of the food item containing the P30.
Table 1.
Meal menus for each experiment.
Experiment no. | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Experiment | Clear soup | Miso soup | Milk soup | Raw egg sauce |
| ||||
Meal menu | ||||
Main dish | Grilled salmon with Japanese radish marinated in citrus juice | |||
Side dish | Boiled spinach flavored with bonito flakes and soy sauce | |||
Staple food | Rice | Rice | Rice | Rice with stirred raw egg saucea |
Soup | Clear soupa | Miso soupa | Milk soupa | Miso soup |
Other | — | — | — | — |
| ||||
Nutrient content per serve | ||||
Energy (kcal) | 336 | 356 | 437 | 430 |
Protein (g) | 20.1 | 21.5 | 25.1 | 27.5 |
Fat (g) | 3.6 | 4.3 | 9.3 | 9.4 |
Carbohydrate (g) | 54.1 | 56.5 | 61.3 | 56.4 |
CoQ10 (mg)b | 120 | 120 | 120 | 120 |
aP30 was suspended in this food item; bonly CoQ10 obtained from P30 is recorded.
The nutrient content of the meals was estimated using Calorie Make software (Toyo System Science Co., Ltd., Yokohama, Japan). The consumption of the meals started around 12:00 h, at least 3 h after breakfast. The control and test experiments were performed between March and December 2018 at intervals of 6–14 weeks. All subjects gave their informed consent for inclusion before they participated in this study. This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Wayo Women's University Human Research Ethics Committee (no. 1734).
2.3. Blood Collection and CoQ10 Measurements
Blood samples were drawn from a vein at the baseline (just before meal ingestion), and 1.5, 3, and 5 h after the start of the meal, and serum was obtained by centrifugation after clot formation. Quantitative analysis of serum CoQ10 concentration was measured by Kaneka Techno Research Co., Ltd., using liquid chromatography with tandem mass spectrometry (LC/MS/MS) [43, 44]. In brief, 0.7 mL of the isopropanol was added to 0.1 mL of serum, mixed, and stored at −80°C until just before the analysis. After centrifugation, the supernatant was filtered through a membrane filter. Then, 200 μL aliquots were mixed with 200 μL of methanol and 50 µL of oxidized CoQ9 (50 ng/mL in 2-propanol) as an internal standard and used as the sample for LC/MS/MS, which was performed using an AB Sciex Triple Quad 5500 LC-MS/MS system and a reversed-phase octadecyl-silica column (AB Sciex, Framingham, MA, USA). The intra- and interday coefficients of variation for CoQ10 were less than 2 and 10%, respectively.
2.4. Data Analysis
The increase in concentration of CoQ10 in the serum after the ingestion of a CoQ10-suspended test meal (ΔCoQ10) was calculated by subtracting the baseline value, and numerical data are expressed as mean ± SD. To compare the bioavailabilities of CoQ10, the areas under the serum CoQ10 concentration-time curves up to 5 h after ingestion (ΔAUC0–5) were calculated. These data were analyzed using one-way analysis of variance (ANOVA) with unpaired and repeated measures, and the differences between the means were evaluated by Holm–Bonferroni post hoc testing using js-STAR ver. 9. 3. 0j web application software (http://www.kisnet.or.jp/nappa/software/star/). P < 0.05 was considered to represent statistical significance.
3. Results
Thirteen healthy volunteers (1 man and 12 women) participated in the study. Each ingested a CoQ10 supplement in the form of suspended a suspension in a food item on up to four separate occasions. Twelve participated in the first experiment (supplemental CoQ10 in clear soup as a reference), thirteen participated in the second experiment (supplemental CoQ10 in miso soup), nine participated in the third experiment (supplemental CoQ10 in milk soup), and thirteen participated in the fourth experiment (supplemental CoQ10 in a raw egg sauce). The participation of each individual and the increases in serum total CoQ10 concentration after each meal are shown in Tables and , respectively. ΔAUC0–5 was also calculated for each participant ().
First, the increase in serum total CoQ10 (ΔCoQ10) concentration after each of the four experiments were compared using unpaired one-way ANOVA and Holm–Bonferroni post hoc testing because some participants missed in the first and third experiments. The concentration achieved following the consumption of P30 in miso soup was significantly higher than that achieved following consumption of the raw egg sauce after 1.5 h and higher than that achieved following all three other meals after 3 h (). There were significant differences in ΔAUC0–5 between the clear soup and miso soup days, and between the miso soup and raw egg sauce days (). The ΔAUC0–5 following miso soup ingestion was 4.44 ± 1.40 μmol h/L, which is approximately 1.5- and 1.6-fold higher (P < 0.05) than that on the clear soup (2.97 ± 1.11 μmol h/L) and raw egg sauce (2.84 ± 1.36 μmol h/L) days, respectively ().
Then, we reanalyzed the data from the eight participants (numbers 3, 4, 5, 8, 9, 11, 12, and 13) who had participated in all of the four experiments (), using one-way ANOVA with repeated measures (Figure 1). The ΔCoQ10 on the miso soup day was significantly higher than on the raw egg sauce days after 1.5 h and higher than on all of the other 3 days 3 h after ingestion (Figure 1(a)). The mean ΔAUC0–5 on the miso soup day was 4.94 ± 1.51 μmol h/L, which was 1.6∼1.7-fold higher (P < 0.05) than that on the clear soup (3.08 ± 1.33 μmol h/L), milk soup (2.95 ± 1.07 μmol h/L), and raw egg sauce (3.05 ± 1.64 μmol h/L) days, respectively (Figure 1(b)).
Figure 1.
Changes in serum total CoQ10 concentration (a) and a comparison of ΔAUC0–5 (b) after the consumption of P30 in clear soup, P30 in miso soup, P30 in milk soup, or P30 in raw egg sauce. 120 mg of CoQ10 was administered. In Figure 1(a), the open circle represents P30 in clear soup, closed circle represents P30 in miso soup, open triangle represents P30 in milk soup, and open square indicates P30 in raw egg sauce. Data are mean ± SD for the eight individuals who participated in all four of the experiments. Figure 1(b) shows box plots for the ΔAUC0–5 for these eight participants. The boundary of the box closest to zero indicates the 25th percentile, the line within the box indicates the median, the multiplication sign within the box indicates the mean, and the boundary of the box farthest from the origin indicates the 75th percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Data were analyzed with one-way analysis of variance with repeated measures, and differences between the means were evaluated using Holm–Bonferroni post hoc tests. Different lower case letters indicate significant differences, with P < 0.05.
These results demonstrate that the absorption rate and bioavailability of supplemental reduced CoQ10 up to 5 h after ingestion was increased by suspending it in miso soup. However, this effect was abolished when the CoQ10 was suspended in raw egg sauce, even if miso soup was ingested at the same time (experiment 4).
4. Discussion
In this study, we determined whether the absorption of a CoQ10 supplement would be affected when it was suspended in specific foods. There were no differences in either ΔCoQ10 or ΔAUC0–5 among participants who consumed a clear soup and test meals on different days, with the exception of the day they consumed the supplement in miso soup. Both the ΔCoQ10 at 3 h and the ΔAUC0–5 for CoQ10 after ingestion of the miso soup was significantly higher than after ingestion of clear soup, milk soup, or raw egg sauce (Figure 1(a)). This result suggests that the suspension of P30 in miso soup may be an effective way of increasing the bioavailability of orally administered CoQ10, especially for older people, as the frequency of miso soup consumption is increased with age in Japanese [45].
Interestingly, the effect of miso soup on the absorption of CoQ10 was abolished when P30 was suspended in raw egg sauce, despite miso soup also being consumed. This suggests that an interaction between the reduced form of CoQ10 and a component of miso might be necessary for the increase in bioavailability of CoQ10 achieved by the consumption of miso soup. The absorption of orally administered CoQ10 is improved when emulsified with a surfactant that has a higher hydrophile-lipophile balance value [46]. Soy proteins have emulsifying and interfacial properties [47], and the amino-carbonyl reaction of soy proteins with sugar improves their emulsifying properties [48]. Some of the soy proteins in miso are modified by the amino-carbonyl reaction, which explains its brown color. Thus, these modified proteins in miso might be candidates for the components responsible for the enhancement of CoQ10 absorption, by emulsification. Besides, miso and soybean extracts improve zinc absorption via increasing cell surface abundance of a zinc transporter [49, 50]. Some components in miso might affect the expression and the activity of a CoQ10 transporter protein. However, further studies are required to determine the identity of the active component(s) and the mechanisms involved in the enhanced absorption of CoQ10. The miso used in the present study contained only 3.76 and 0.02 μg of the reduced and oxidized forms of CoQ10 per g miso (data not shown), and 10 g of the miso was used for the preparation of one serving of miso soup; therefore, it is unlikely that the CoQ10 contributed by the miso is involved in the enhancement in bioavailability of CoQ10.
We also estimated the ΔAUC value for the reduced form of CoQ10 in the previously published study to compare these with the ΔAUC0–5 values obtained in the present study. Hosoe et al. performed a single-dose experiment after meal ingestion using 150 mg of the reduced form of CoQ10 in a soft capsule [27]. The estimated ΔAUC for the first 6 h after ingestion (ΔAUC0–6) in this study was 2.9 μmol h/L, whereas the ΔAUC0–5 in our control experiment, in which 120 mg of the reduced form of CoQ10 was consumed in a clear soup was 2.97 ± 1.11 μmol h/L (Experiment 1 in ), suggesting that similar results can be obtained when the reduced form of CoQ10 is administered. The ΔAUC0–5 associated with P30-plus-miso ingestion (4.44 ± 1.40 μmol h/L, Experiment 2 in ) was >1.5 times higher than those associated with the ingestion of other foods (clear soup, milk soup, and raw egg sauce), implying that the ingestion of CoQ10 suspended in miso soup is one of the best ways of increasing its bioavailability, at least, when P30 is used.
One limitation of our study was that the serum concentrations of CoQ10 were determined only up to 5 h after ingestion because of the research environment and availability of the participants. In contrast, in most previous studies, these concentrations were determined up to 12 or 24 h after a single dose of CoQ10. One could argue that miso soup may accelerate rather than enhance CoQ10 absorption, as the maximum CoQ10 concentration or the maximum CoQ10 concentration-time could not be determined. The half-life of CoQ10 in plasma may reach 33 h, and 5 to 6 days were required for plasma CoQ10 levels to return to baseline following a single dose [51]. The possibility of overestimation of the effect of miso soup on CoQ10 absorption cannot be denied.
Another limitation of our study was that there is no negative control, i.e., meals alone. In the previous reports, there was no placebo control for the determination of the absorption/bioavailability of CoQ10 supplements [25–27, 52–55]. Also, the effect of CoQ10 contents in the provided meals seemed to be extremely low as the estimated CoQ10 amount was less than one two-hundredth of the CoQ10 supplements ingested. However, these remain in a matter of speculation.
To further characterize the effects of miso soup ingestion on the bioavailability of CoQ10, it would be of interest to compare the serum concentrations of CoQ10 after multiple meals of miso soup or water containing P30 with or after meals for several weeks. The significance of the present findings will be evaluated by performing such a clinical experiment in the near future.
5. Conclusions
In conclusion, the ingestion of a granulated and reduced form of CoQ10 in miso soup increased the bioavailability of CoQ10 by ∼1.5 times over its ingestion under the other conditions tested. Thus, the absorption of a CoQ10 supplement can be enhanced by combining it with specific food substances, such as miso, in addition to taking it with a meal per se.
Acknowledgments
The authors thank Dr. Kenji Fujii of Kaneka Corporation for providing the granulated reduced CoQ10 supplement and analyzing the serum CoQ10 concentrations. They also thank Ms. Hitomi Kobayashi, Ms. Miku Hatsushiba, and Ms. Ayaka Hanada for their help with meal preparation for the clinical study. Finally, they thank Mark Cleasby, Ph.D., from Edanz Group (http://www.edanzediting.com/ac) for editing a draft of this manuscript. This study was supported by funding from the Kaneka Corporation (Osaka, Japan), on the basis of a contract between Kaneka and Wayo Women's University.
Data Availability
The data used to support the findings of this study are included within the article and also available upon request.
Disclosure
The sponsors had no role in the design, execution, interpretation, or writing of the study.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Authors' Contributions
T. S. conceptualized the study; M. T. and T. S. took part in clinical study design, collection of laboratory data, and writing of the original draft; and M. T., M. N., T. K., and T. S. conducted the clinical study and read, revised, and approved the final version of the manuscript.
Supplementary Materials
Figure S1: Meals provided to the participants. Figure S2: Changes in serum total CoQ10 using unpaired one-way ANOVA. Table S1: Participation in each of the four experiments. Table S2: The increase in serum total CoQ10 concentration of each subject after the consumption of each food type.
References
- 1.Crane F. L. Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition. 2001;20(6):591–598. doi: 10.1080/07315724.2001.10719063. [DOI] [PubMed] [Google Scholar]
- 2.López-Lluch G., Rodríguez-Aguilera J. C., Santos-Ocaña C., Navas P. Is coenzyme Q a key factor in aging? Mechanisms of Ageing and Development. 2010;131(4):225–235. doi: 10.1016/j.mad.2010.02.003. [DOI] [PubMed] [Google Scholar]
- 3.Frei B., Kim M. C., Ames B. N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proceedings of the National Academy of Sciences. 1990;87(12):4879–4883. doi: 10.1073/pnas.87.12.4879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kalén A., Appelkvist E.-L., Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24(7):579–584. doi: 10.1007/bf02535072. [DOI] [PubMed] [Google Scholar]
- 5.Ravaglia G., Forti P., Maioli F., et al. Coenzyme Q10 plasma levels and body composition in elderly males. Archives of Gerontology and Geriatrics. 1996;22(1):539–543. doi: 10.1016/0167-4943(96)86996-2. [DOI] [PubMed] [Google Scholar]
- 6.Takahashi M., Suzuki T., Matsumoto H., Kaneko T., Nukada H., Hashizume N. Decreased blood levels of L-carnitine and coenzyme Q10 in long-term hospitalized people. New Diet Therapy. 2014;30(3):23–33. [Google Scholar]
- 7.Adarsh K., Kaur H., Mohan V. Coenzyme Q10(CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM) Biofactors. 2008;32(1–4):145–149. doi: 10.1002/biof.5520320117. [DOI] [PubMed] [Google Scholar]
- 8.McMurray J. J. V., Dunselman P., Wedel H., et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure) Journal of the American College of Cardiology. 2010;56(15):1196–1204. doi: 10.1016/j.jacc.2010.02.075. [DOI] [PubMed] [Google Scholar]
- 9.Miyake Y., Shouzu A., Nishikawa M., et al. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung. 2011;49(4):324–329. doi: 10.1055/s-0031-1300422. [DOI] [PubMed] [Google Scholar]
- 10.Gazdíková K., Gvozdjáková A., Kucharská J., Spustová V., Braunová Z., Dzúrik R. Oxidative stress and plasma concentrations of coenzyme Q. Nephron. 2001;88(3):p. 285. doi: 10.1159/000046007. [DOI] [PubMed] [Google Scholar]
- 11.Yamamoto Y., Yamashita S. Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. Biofactors. 1999;9(2–4):241–246. doi: 10.1002/biof.5520090219. [DOI] [PubMed] [Google Scholar]
- 12.Rosenfeldt F. L., Haas S. J., Krum H., et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension. 2007;21(4):297–306. doi: 10.1038/sj.jhh.1002138. [DOI] [PubMed] [Google Scholar]
- 13.Golbidi S., Ebadi S. A., Laher I. Antioxidants in the treatment of diabetes. Current Diabetes Reviews. 2011;7(2):106–125. doi: 10.2174/157339911794940729. [DOI] [PubMed] [Google Scholar]
- 14.Henchcliffe C., Beal M. F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature Clinical Practice Neurology. 2008;4(11):600–609. doi: 10.1038/ncpneuro0924. [DOI] [PubMed] [Google Scholar]
- 15.Moccia M., Capacchione A., Lanzillo R., et al. Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis. Therapeutic Advances in Neurological Disorders. 2019;12 doi: 10.1177/1756286418819074.1756286418819074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hofman-Bang C., Rehnqvist N., Swedberg K., Wiklund I., Astrom H. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure: the Q10 study group. Journal of Cardiac Failure. 1995;1(2):101–107. doi: 10.1016/1071-9164(95)90011-x. [DOI] [PubMed] [Google Scholar]
- 17.Deguchi S., Fujii K., Kurihara T. The effect of the reduced form of coenzyme Q10 (ubiquinol, Kaneka QH™) on QOL improvement in the elderly. Journal of Clinical Therapeutics & Medicines. 2008;24(3):233–238. [Google Scholar]
- 18.Lister R. E. An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. Journal of International Medical Research. 2002;30(2):195–199. doi: 10.1177/147323000203000213. [DOI] [PubMed] [Google Scholar]
- 19.Castro-Marrero J., Cordero M. D., Segundo M. J., et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015;22(8):679–685. doi: 10.1089/ars.2014.6181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Castro-Marrero J., Saez-Francas N., Segundo M. J., et al. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome—a randomized, controlled, double-blind trial. Clinical Nutrition. 2016;35(4):826–834. doi: 10.1016/j.clnu.2015.07.010. [DOI] [PubMed] [Google Scholar]
- 21.Miyamae T., Seki M., Naga T., et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Report. 2013;18(1):12–19. doi: 10.1179/1351000212y.0000000036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Berman M., Erman A., Ben-Gal T., et al. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Clinical Cardiology. 2004;27(5):295–299. doi: 10.1002/clc.4960270512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Monsef A., Shahidi S., Komaki A. Influence of chronic coenzyme Q10 supplementation on cognitive function, learning, and memory in healthy and diabetic middle-aged rats. Neuropsychobiology. 2019;77(2):92–100. doi: 10.1159/000495520. [DOI] [PubMed] [Google Scholar]
- 24.Andreani C., Bartolacci C., Guescini M., et al. Combination of coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model. Oxidative Medicine and Cellular Longevity. 2018;2018:15. doi: 10.1155/2018/8936251.8936251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Barakat A., Shegokar R., Dittgen M., Müller R. H. Coenzyme Q10 oral bioavailability: effect of formulation type. Journal of Pharmaceutical Investigation. 2013;43(6):431–451. doi: 10.1007/s40005-013-0101-4. [DOI] [Google Scholar]
- 26.Qin B., Liu L., Pan Y., et al. PEGylated solanesol for oral delivery of coenzyme Q10. Journal of Agricultural and Food Chemistry. 2017;65(16):3360–3367. doi: 10.1021/acs.jafc.7b00165. [DOI] [PubMed] [Google Scholar]
- 27.Hosoe K., Kitano M., Kishida H., Kubo H., Fujii K., Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regulatory Toxicology and Pharmacology. 2007;47(1):19–28. doi: 10.1016/j.yrtph.2006.07.001. [DOI] [PubMed] [Google Scholar]
- 28.Ochiai A., Itagaki S., Kurokawa T., Kobayashi M., Hirano T., Iseki K. Improvement in intestinal coenzyme Q10 absorption by food intake. Yakugaku Zasshi. 2007;127(8):1251–1254. doi: 10.1248/yakushi.127.1251. [DOI] [PubMed] [Google Scholar]
- 29.Takeda S., Kimura M., Marushima R., et al. Mayonnaise contributes to increasing postprandial serum beta-carotene concentration through the emulsifying property of egg yolk in rats and humans. Journal of Nutritional Science and Vitaminology (Tokyo) 2011;57(3):209–215. doi: 10.3177/jnsv.57.209. [DOI] [PubMed] [Google Scholar]
- 30.Unlu N. Z., Bohn T., Clinton S. K., Schwartz S. J. Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. The Journal of Nutrition. 2005;135(3):431–436. doi: 10.1093/jn/135.3.431. [DOI] [PubMed] [Google Scholar]
- 31.Kim J. E., Ferruzzi M. G., Campbell W. W. Egg consumption increases vitamin E absorption from Co-consumed raw mixed vegetables in healthy young men. The Journal of Nutrition. 2016;146(11):2199–2205. doi: 10.3945/jn.116.236307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bach Kristensen M., Hels O., Morberg C., Marving J., Bugel S., Tetens I. Pork meat increases iron absorption from a 5-day fully controlled diet when compared to a vegetarian diet with similar vitamin C and phytic acid content. British Journal of Nutrition. 2005;94(1):78–83. doi: 10.1079/bjn20051417. [DOI] [PubMed] [Google Scholar]
- 33.Hunt J. R., Gallagher S. K., Johnson L. K. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. The American Journal of Clinical Nutrition. 1994;59(6):1381–1385. doi: 10.1093/ajcn/59.6.1381. [DOI] [PubMed] [Google Scholar]
- 34.Siegenberg D., Baynes R. D., Bothwell T. H., et al. Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption. The American Journal of Clinical Nutrition. 1991;53(2):537–541. doi: 10.1093/ajcn/53.2.537. [DOI] [PubMed] [Google Scholar]
- 35.Riedl J., Linseisen J., Hoffmann J., Wolfram G. Some dietary fibers reduce the absorption of carotenoids in women. The Journal of Nutrition. 1999;129(12):2170–2176. doi: 10.1093/jn/129.12.2170. [DOI] [PubMed] [Google Scholar]
- 36.Samman S., Sandstrom B., Toft M. B., et al. Green tea or rosemary extract added to foods reduces nonheme-iron absorption. The American Journal of Clinical Nutrition. 2001;73(3):607–612. doi: 10.1093/ajcn/73.3.607. [DOI] [PubMed] [Google Scholar]
- 37.Cook J. D., Reddy M. B., Burri J., Juillerat M. A., Hurrell R. F. The influence of different cereal grains on iron absorption from infant cereal foods. The American Journal of Clinical Nutrition. 1997;65(4):964–969. doi: 10.1093/ajcn/65.4.964. [DOI] [PubMed] [Google Scholar]
- 38.Hallberg L., Rossander-Hulthen L., Brune M., Gleerup A. Inhibition of haem-iron absorption in man by calcium. British Journal of Nutrition. 1993;69(2):533–540. doi: 10.1079/bjn19930053. [DOI] [PubMed] [Google Scholar]
- 39.Brune M., Rossander L., Hallberg L. Iron absorption and phenolic compounds: importance of different phenolic structures. European Journal of Clinical Nutrition. 1989;43(8):547–557. [PubMed] [Google Scholar]
- 40.Takahashi M., Kinoshita T., Maruyama K., Tanigawa T., Suzuki T. Association between diet habits and blood coenzyme Q10 levels among residents in Kamijima-cho, Ehime. The Journal of Wayo Women’s University. 2016;56:123–132. [Google Scholar]
- 41.Takahashi M., Kinoshita T., Kaneko T., Suzuki T. Investigation of the influence of dietary habits on serum coenzyme Q10 level with long-term CoQ10 supplement intake. The Journal of Wayo Women’s University. 2018;58:111–118. [Google Scholar]
- 42.Kubo H., Fujii K., Kawabe T., Matsumoto S., Kishida H., Hosoe K. Food content of ubiquinol-10 and ubiquinone-10 in the Japanese diet. Journal of Food Composition and Analysis. 2008;21(3):199–210. doi: 10.1016/j.jfca.2007.10.003. [DOI] [Google Scholar]
- 43.Uchida Y., Wakimoto K., Takahashi H., Fujii K. The bioavailability of reduced coenzyme Q10 water-dispersed powder after a single oral dose. Japanese Journal of Complementary and Alternative Medicine. 2014;11:103–105. [Google Scholar]
- 44.Ushikoshi-Nakayama R., Ryo K., Yamazaki T., et al. Effect of gummy candy containing ubiquinol on secretion of saliva: a randomized, double-blind, placebo-controlled parallel-group comparative study and an in vitro study. PLoS One. 2019;14(4) doi: 10.1371/journal.pone.0214495.e0214495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Wakasugi M., James Kazama J., Narita I. Associations between the intake of miso soup and Japanese pickles and the estimated 24-hour urinary sodium excretion: a population-based cross-sectional study. Internal Medicine. 2015;54(8):903–910. doi: 10.2169/internalmedicine.54.4336. [DOI] [PubMed] [Google Scholar]
- 46.Sato Y., Mutoh H., Suzuki M., Takekuma Y., Iseki K., Sugawara M. Emulsification using highly hydrophilic surfactants improves the absorption of orally administered coenzyme Q10. Biological and Pharmaceutical Bulletin. 2013;36(12):2012–2017. doi: 10.1248/bpb.b13-00447. [DOI] [PubMed] [Google Scholar]
- 47.Tang C. H. Emulsifying properties of soy proteins: a critical review with emphasis on the role of conformational flexibility. Critical Reviews in Food Science and Nutrition. 2017;57(12):2636–2679. doi: 10.1080/10408398.2015.1067594. [DOI] [PubMed] [Google Scholar]
- 48.Li R., Wang X., Liu J., et al. Relationship between molecular flexibility and emulsifying properties of soy protein isolate-glucose conjugates. Journal of Agricultural and Food Chemistry. 2019;67(14):4089–4097. doi: 10.1021/acs.jafc.8b06713. [DOI] [PubMed] [Google Scholar]
- 49.Hashimoto A., Kambe T. Approaches to the improvement of zinc nutrition by fermented soy foods like miso: effects on expression of zinc transporter involved in zinc absorption in the intestinal epithelial cells. Journal of the Brewing Society of Japan. 2011;106(12):811–817. doi: 10.6013/jbrewsocjapan.106.811. [DOI] [Google Scholar]
- 50.Hashimoto A., Ohkura K., Takahashi M., et al. Soybean extracts increase cell surface ZIP4 abundance and cellular zinc levels: a potential novel strategy to enhance zinc absorption by ZIP4 targeting. Biochemical Journal. 2015;472(2):183–193. doi: 10.1042/bj20150862. [DOI] [PubMed] [Google Scholar]
- 51.Miles M. V. The uptake and distribution of coenzyme Q10. Mitochondrion. 2007;7(l):S72–S77. doi: 10.1016/j.mito.2007.02.012. [DOI] [PubMed] [Google Scholar]
- 52.Lopez-Lluch G., Del Pozo-Cruz J., Sanchez-Cuesta A., Cortes-Rodriguez A. B., Navas P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2019;57:133–140. doi: 10.1016/j.nut.2018.05.020. [DOI] [PubMed] [Google Scholar]
- 53.Martucci A., Reurean-Pintilei D., Manole A. Bioavailability and sustained plasma concentrations of CoQ10 in healthy volunteers by a novel oral timed-release preparation. Nutrients. 2019;11(3) doi: 10.3390/nu11030527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Nukui K., Yamagishi T., Miyawaki H., Kettawan A., Okamoto T., Sato K. Comparison of uptake between PureSorb-Q™40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake. Journal of Nutritional Science and Vitaminology. 2007;53(2):187–190. doi: 10.3177/jnsv.53.187. [DOI] [PubMed] [Google Scholar]
- 55.Ozaki A., Muromachi A., Sumi M., Sakai Y., Morishita K., Okamoto T. Emulsification of coenzyme Q10 using gum Arabic increases bioavailability in rats and human and improves food-processing suitability. Journal of Nutritional Science and Vitaminology. 2010;56(1):41–47. doi: 10.3177/jnsv.56.41. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S1: Meals provided to the participants. Figure S2: Changes in serum total CoQ10 using unpaired one-way ANOVA. Table S1: Participation in each of the four experiments. Table S2: The increase in serum total CoQ10 concentration of each subject after the consumption of each food type.
Data Availability Statement
The data used to support the findings of this study are included within the article and also available upon request.